1. (1) As used in this section, “generic drug” means:

   1. (a) A retail drug that is marketed or distributed in accordance with an abbreviated new drug application approved under 21 U.S.C. 355(j);
   2. (b) An authorized generic as defined by 42 C.F.R. 447.502; or
   3. (c) A drug that entered the market before 1962 that was not originally marketed under a new drug application.

2. (2) The status of the generic drug market includes but is not limited to:

   1. (a) The prices of generic drugs on a year-to-year basis;
   2. (b) The degree to which generic drug prices affect insurance premiums;
   3. (c) Annual changes in health insurance cost-sharing for generic drugs;
   4. (d) The potential for and history of generic drug shortages; and
   5. (e) The degree to which generic drug prices affect annual spending in the state medical assistance program.

[2021 c.598 §6; 2025 c.166 §4]